Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer

Showing 15 posts of 258 posts found.

Bayer image

Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug

October 16, 2018
Manufacturing and Production Bayer, CCG, NHS, Novartis, avastin, wet AMD

Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning …

News
martin_van_trieste

Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO

October 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals

Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …

Appointment

Bayer to cut 227 positions in California to drive efficiency in haemophilia

October 4, 2018
Manufacturing and Production Bayer, haemophilia, pharma

Bayer has announced its intention to axe 227 employees at a manufacturing site in California as part of a push …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

News

Courts back NHS in fight against Novartis and Bayer

September 24, 2018
Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …

News
ipos0_l

Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration

August 20, 2018
Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …

News
Bayer

Bayer expands Broad Institute partnership to focus on heart failure

July 3, 2018
Manufacturing and Production, Research and Development Bayer, broad institute, collaboration, heart failure, pharma

The Broad Institute of MIT and Harvard has expanded its partnership with Bayer through the launch of the Precision Cardiology …

News
bayer_cross_2

Bayer eyes R&D cuts, as Monsanto deal raises question of focus

June 1, 2018
Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical

When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …

News
essure

Bayer contraceptive implant public backlash brings results

April 12, 2018
Medical Communications, Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …

News
bayer_cross_2

Bayer-Monsanto deal one step closer, after EU nod

March 22, 2018
Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical

The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …

News

NICE recommends thyroid cancer drug trio for NHS use

February 20, 2018
Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer

NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, HIV, J&J, JJ, Johnson & Johnson, Pfizer, Shire, Teva, Xarelto, patient reported outcomes

The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …

News
xarelto_10_tablet1

Bayer and J&J successfully reverse $28 million Xarelto court payout

January 10, 2018
Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma

Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …

News
busch

Pharma carousel sees Bayer discovery chief head to Shire

December 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Shire, biotech, drugs, pharma, pharmaceutical

It’s no secret that when individuals leave companies within the pharma industry, they tend to pop up at a rival …

Appointment

Bayer’s $175 million pneumonia drug fails at phase 3

November 27, 2017
Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023